etherna immunotherapies

Niel, Belgium

etherna develops mRNA and lipid nanoparticle solutions.

Aug 2022

Series B

Biotechnology Health Care Medical Device Therapeutics

Top Investors

Omega FundsEQT Life SciencesBoehringer Ingelheim Venture FundEuropean CommissionNovalis LifeSciences

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about etherna immunotherapies

Who are etherna immunotherapies's investors?

etherna immunotherapies's investors include Omega Funds, EQT Life Sciences, Boehringer Ingelheim Venture Fund, European Commission, Novalis LifeSciences.

Where is etherna immunotherapies headquartered?

etherna immunotherapies is headquartered in Niel, Belgium.

What does etherna immunotherapies do?

etherna develops mRNA and lipid nanoparticle solutions.

What stage is etherna immunotherapies at?

etherna immunotherapies is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 23, 2022.

MLA

"etherna immunotherapies — Funding & Investors." VCBacked, August 23, 2022, https://www.vcbacked.co/company/etherna-immunotherapies. Accessed July 1, 2026.

APA

VCBacked. (2022). etherna immunotherapies — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/etherna-immunotherapies

Wikipedia (cite web)

{{cite web |title=etherna immunotherapies — Funding & Investors |url=https://www.vcbacked.co/company/etherna-immunotherapies |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 23, 2022.